Literature DB >> 22213655

Systems biology analysis of protein-drug interactions.

Jacques Colinge1, Uwe Rix, Keiryn L Bennett, Giulio Superti-Furga.   

Abstract

Drugs induce global perturbations at the molecular machinery level because their cognate targets are involved in multiple biological functions or because of off-target effects. The analysis or the prediction of such systems level consequences of drug treatment therefore requires the application of systems biology concepts and methods. In this review, we first summarize the methods of chemical proteomics that can measure unbiased and proteome-wide drug protein target spectra, which is an obvious necessity to perform a global analysis. We then focus on the introduction of computational methods and tools to relate such target spectra to global models such as pathways and networks of protein-protein interactions, and to integrate them with existing protein functional annotations. In particular, we discuss how drug treatment can be mapped onto likely affected biological functions, how this can help identifying drug mechanisms of action, and how such mappings can be exploited to predict potential side effects and to suggest new indications for existing compounds.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Mesh:

Substances:

Year:  2011        PMID: 22213655     DOI: 10.1002/prca.201100077

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  9 in total

Review 1.  Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders.

Authors:  Yu Chen; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-03-23       Impact factor: 13.820

2.  Targeting a cell state common to triple-negative breast cancers.

Authors:  Markus K Muellner; Barbara Mair; Yasir Ibrahim; Claudia Kerzendorfer; Hannelore Lechtermann; Claudia Trefzer; Freya Klepsch; André C Müller; Ernestine Leitner; Sabine Macho-Maschler; Giulio Superti-Furga; Keiryn L Bennett; José Baselga; Uwe Rix; Stefan Kubicek; Jacques Colinge; Violeta Serra; Sebastian M B Nijman
Journal:  Mol Syst Biol       Date:  2015-02-19       Impact factor: 11.429

3.  A network inference method for large-scale unsupervised identification of novel drug-drug interactions.

Authors:  Roger Guimerà; Marta Sales-Pardo
Journal:  PLoS Comput Biol       Date:  2013-12-05       Impact factor: 4.475

4.  Investigating the mechanisms of Modified Xiaoyaosan (tiaogan-liqi prescription) in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation.

Authors:  Mingtai Chen; Yong Luo; Ling Men; Bo Lin; Haidan Lin; Ying Li; Guofu Zhong; Xiaoling Zhong; Wenjun Fu; Hua Zhou; Guangdong Tong; Qiang Liu; Jienan Luan
Journal:  Aging (Albany NY)       Date:  2021-04-04       Impact factor: 5.682

5.  Network pharmacology-based analysis in determining the mechanisms of Huoxin pill in protecting against myocardial infarction.

Authors:  Jia He; Da Wo; En Ma; Qing Wang; Jinxiao Chen; Jun Peng; Weidong Zhu; Dan-Ni Ren
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

6.  Mechanisms of magnoliae cortex on treating sarcopenia explored by GEO gene sequencing data combined with network pharmacology and molecular docking.

Authors:  Xingqi Zhao; Feifei Yuan; Haoyang Wan; Hanjun Qin; Nan Jiang; Bin Yu
Journal:  BMC Genom Data       Date:  2022-02-17

7.  A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALL.

Authors:  Uwe Rix; Jacques Colinge; Katharina Blatt; Manuela Gridling; Lily L Remsing Rix; Katja Parapatics; Sabine Cerny-Reiterer; Thomas R Burkard; Ulrich Jäger; Junia V Melo; Keiryn L Bennett; Peter Valent; Giulio Superti-Furga
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

8.  Bioinformatics analysis for the antirheumatic effects of huang-lian-jie-du-tang from a network perspective.

Authors:  Haiyang Fang; Yichuan Wang; Tinghong Yang; Yang Ga; Yi Zhang; Runhui Liu; Weidong Zhang; Jing Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-21       Impact factor: 2.629

9.  Building and exploring an integrated human kinase network: global organization and medical entry points.

Authors:  Jacques Colinge; Adrián César-Razquin; Kilian Huber; Florian P Breitwieser; Peter Májek; Giulio Superti-Furga
Journal:  J Proteomics       Date:  2014-04-03       Impact factor: 4.044

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.